Founded in 2014, PhenoVista is a leader in the development and implementation of multiplexed, high-content, imaging-based, phenotypic assays for biopharmaceutical clients. These assays deliver the high-quality, quantitative data needed to inform and de-risk critical R&D decisions with greater confidence. Clients gain access to novel insights related to the complex biology underlying target validation, therapeutic delivery, efficacy and safety, cytotoxicity, and mechanisms of action, increasing the likelihood of success of first-in-class drug candidates.
PhenoVista Biosciences
PhenoVista is a leader in the development and implementation of multiplexed, high-content, imaging-based, phenotypic assays for biopharmaceutical clients.
The Latest Insights & Innovations from
PhenoVista Biosciences
Blog
High-content Cellular Imaging Assays Designed to Enable Discovery and Development of Safe, Efficacious Therapeutics
November 3, 2022
Learn more
No items found.
No items found.